Indivior (LON:INDV) Stock Price Down 19.5% – Here’s What Happened

Indivior PLC (LON:INDV)’s stock price fell 19.5% during trading on Thursday . The company traded as low as GBX 640 ($8.09) and last traded at GBX 698.90 ($8.83). 1,716,748 shares changed hands during trading, an increase of 144% from the average session volume of 704,709 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.74) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The firm has a market capitalization of £1.08 billion, a PE ratio of -570.87, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The stock’s 50-day moving average price is GBX 920.11 and its 200 day moving average price is GBX 850.81. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.